Here’s the business plan – Own Snap
In the last 12 months or so, the stock from Vaxart Inc (NASDAQ: VXRT) has had a pretty roller coaster ride and it was understandable.
The company is a vaccine specialist and its work on a COVID 19 vaccine has brought it to the attention of many investors. Recently, there was a discussion on Motley Fool Live regarding the merits of holding onto the stock after the latest results were released regarding its COVID 19 vaccine.
One of the experts who participated in the discussion said that while the stock declined after the data was released, Vaxart’s story hasn’t changed much.
Therefore, in this situation, it might be a good decision for investors to hold on to the stock and see how it all plays out in the end. However, another expert noted that even if the company invented a vaccine, it might be too late for Vaxart to gain significant market share.
Biotech, Tech and Crypto journalist
Anthony Gonzales brings 3 years of experience to help grassroots, mid-size organizations and large institutions build their management and resource generation capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is also the St. Marco University of Science and Technology Gold Medalist in the Bachelor of Financial Management.